FHCQX
ETF
FHCQX
·
UNKNOWN
·
110 holdings
Quick Summary
Price History
Concentration Risk
40.08%
Top-heavy
Low risk
High risk
The top 10 holdings account for 40.08%. The biggest positions move the needle, but there's enough spread to cushion a single-stock blowup.
Top Holdings Today
Weighted by position size
BSX
▼ -0.45%
LLY
▼ -0.44%
DHR
▼ -1.93%
PEN
▼ -0.03%
ARGX
▼ -0.49%
ALNY
▼ -1.68%
MASI
▼ -0.01%
CVS
▲ 0.81%
ASND
▼ -0.16%
Weighted avg. of top holdings
▼ -0.60%
Sector Allocation
Healthcare
84.48%
Technology
0.89%
Manufacturing
0.86%
Top 10 Holdings
40.08% of fund
All Holdings (110)
| # | Ticker | Name | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | BSX | BOSTON SCIENTIFIC CORP | 6.47% | 4.25 M | 431.72 M |
| 2 | LLY | ELI LILLY and CO | 6.45% | 400,000 | 430.19 M |
| 3 | DHR | DANAHER CORP | 6.25% | 1.84 M | 417.28 M |
| 4 | PEN | PENUMBRA INC | 4.39% | 1.00 M | 293.17 M |
| 5 | ARGX | ARGENX SE | 3.47% | 254,000 | 231.64 M |
| 6 | ALNY | ALNYLAM PHARMACEUTICALS INC | 2.74% | 405,000 | 182.75 M |
| 7 | MASI | MASIMO CORP | 2.67% | 1.25 M | 178.04 M |
| 8 | UCB SA | UCB SA | 2.66% | 635,000 | 177.21 M |
| 9 | CVS | CVS HEALTH CORP | 2.63% | 2.18 M | 175.18 M |
| 10 | ASND | ASCENDIS PHARMA A/S | 2.35% | 740,000 | 157.12 M |
Showing top 10 of 110 holdings
·
Listed: 98.37%
·
1.63% in other positions
Related ETFs
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: N/A
Profitability
ROE: N/A · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: N/A
Safety
D/E: N/A · Current: N/A| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: N/A · EV/EBITDA: N/A
Valuation
P/E: N/A · EV/EBITDA: N/A| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | N/A | Enterprise Value | N/A |
Per Share
EPS: N/A · FCF/Share: N/A
Per Share
EPS: N/A · FCF/Share: N/A| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
مقارنة الأقران
مقابل وسيط قطاع ETF (25157 نظير)
مقارنة بشركات مشابهة في ETF
مقارنة الأقران
مقابل وسيط قطاع ETF (25157 نظير) مقارنة بشركات مشابهة في ETF| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | — | — |
| P/B | — | — |
| ROE % | — | — |
| Net Margin % | — | — |
| Rev Growth 5Y % | — | — |
| D/E | — | — |
{"event":"ticker_viewed","properties":{"ticker":"FHCQX","listing_kind":"etf","pathname":"/etfs/fhcqx","exchange":"UNKNOWN","country":"US"}}
